Danaher Corporation NYQ · DHR
Price alert —
Sign in to get a one-time email the moment DHR crosses your price. Free accounts included.
Sign in / create a free accountDanaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.
DHR last traded at $203.83, down 0.6% on the day; that's in the middle part of its 52-week range ($160.93–$242.80). Right now it's trading above its recent average — momentum is positive, though some of the move may already be in the price.
The next scheduled earnings report (2026-07-21) is the biggest known catalyst on the calendar, and after a strong run, watch whether the price can hold its gains on quieter days.
A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.
KC2 upper, +1.81 ATR from EMA21 — doji
- · Doji — indecision, watch for reversal
Each bar shows how many points that factor added. The more points — and the more factors that agree — the higher the letter grade.
- · KC2 upper stretch — standard mean-reversion tier
- · Doji — indecision, watch for reversal
- · RSI hook from overbought (66)
Each bar shows how many points that factor added. The more points — and the more factors that agree — the higher the letter grade.
On the latest daily bar, momentum sits mid-range (RSI 66), the trend is strong (ADX 29), and volume is about normal (1.2×). On the business side, revenue is growing 4% year over year and the business keeps about 19 cents of every sales dollar as free cash.
Latest-bar indicator readings behind the grade — display-only, they don't move the letter.
Company fundamentals for context — display-only, they don't move the grade.
Our cash-flow model pegs fair value near $85.23 (fair range $85–$129); today's price sits 133% above that estimate. The model's verdict is “Overvalued” and accounting quality screens as Weak. Model estimates only — do your own due diligence.
- ✓ Debt/equity 0.59 (antifragile)
- ✓ Positive retained earnings
- ✓ Gross margin 59% (pricing power)
- ⚠ Debt exceeds cash
- ⚠ Goodwill 52% of assets (acquisition-heavy)
- ⚠ Receivables growing faster than revenue
Price implies ~16% growth (vs trailing rev yoy). Model estimate — do your own due diligence.
DHR is a $144.3 billion company, priced at 40× last year's earnings.
Options idea
See more →ITM tracks the stock · OTM is cheaper / more leverage. Model-priced — verify the live chain. As of 2h ago (2026-07-18 18:02 UTC).
Earnings
See more →- Last reported
- 2026-04-21
- EPS (act / est)
- 2.06 / 1.94
- Surprise
- +6.5%
- Next report
- 2026-07-21
About
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and inte…